SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid a sharp intraday reversal, prompting discussions about potential market manipulation and the strength of the AI sector following Nvidia's earnings; traders are actively debating whether this pullback represents a buying opportunity or the start of a deeper correction, with some pointing to possible Yen carry trade issues.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia's stock is trending amid upgrades from analysts, though some community members express concern over valuation relative to competitors and potential interconnect hurdles in the AI sector. Despite strong earnings, the stock experienced a selloff, leading to discussions about a possible short squeeze and whether AI constitutes a bubble.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing heavy volatility, sparking discussions about a potential market correction and whether dip-buying strategies will continue to pay off. Some community members are pointing to broader macroeconomic concerns and the influence of crypto markets, while others are eyeing key support levels for potential reversals. The conversation highlights uncertainty around near-term market direction.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing volatility, sparking debates about a potential market bottom and the influence of large institutional players. Community discussions revolve around whether this dip presents a buying opportunity or signals a deeper correction, with some pointing to macro factors and potential liquidations as drivers. Sentiment is mixed, with bullish and bearish arguments clashing amidst the price swings.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending due to strong Q3 earnings and raised FY26 guidance, sparking bullish sentiment among investors; discussions include the impact of e-commerce growth and a planned move to the Nasdaq. Community members are debating whether Walmart's performance signals broader economic strength or if it's a safe haven during market uncertainty, while also pondering its valuation relative to tech companies.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending downwards, frustrating investors who cite strong deliveries and question the stock's valuation relative to peers. Community members speculate about market manipulation and potential short squeezes while bracing for upcoming earnings. Despite the negative price action, some investors remain optimistic, viewing the current dip as a buying opportunity based on the company's long-term potential.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as the price of Bitcoin fluctuates, impacting MicroStrategy's value as a major BTC holder; the community is closely watching key support levels. Discussions revolve around analyst Tom Lee's commentary and potential short squeezes, with some expressing concerns about solvency and potential liquidation. Recent whale activity and overall market sentiment add to the volatility.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending as traders assess its volatile movements amidst optimism in the AI sector. Community discussions revolve around dip-buying strategies and potential profit-taking points, especially with upcoming earnings from key semiconductor players like NVDA. The ongoing government shutdown and concerns about AI valuations add to the uncertainty surrounding this leveraged ETF.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending following a target price increase from UBS and rising memory prices linked to AI data-center demand, fueling discussions about its growth potential. Community members are weighing the bullish outlook against concerns of an overbought condition after the stock's significant year-to-date gains. Discussions also focus on potential short-term pullbacks versus long-term opportunities in the semiconductor space.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending due to Bitcoin's price volatility, sparking debates on whether to buy the dip or brace for further declines; some community members point to potential manipulation and significant ETF outflows as bearish signals, while others highlight oversold conditions and historical patterns as reasons for optimism, with key options levels around \$50 also in focus.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lyell Immunopharma (NASDAQ:LYEL) Posts Quarterly Earnings Results, Beats Expectations By $0.68 EPS

Lyell Immunopharma (NASDAQ:LYEL - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($2.13) earnings per share for the quarter, beating analysts' consensus...

The Analyst Verdict: Lyell Immunopharma In The Eyes Of 4 Experts

Latest Ratings for LYEL
 DateFirmActionFromTo Jan 2022Morgan StanleyMaintainsOverweight Jul 2021Morgan StanleyInitiates Coverage OnOverweight Jul 2021B of A SecuritiesInitiates Coverage OnBuy...

WisdomTree, Inc. ($WT)Shares of WisdomTree, which offers a suite of exchange-traded and blockchain technology products, reported third-quarter earnings per share (EPS) of $0.18 compared to $0.10 per share a year-ago. This beat the consensus estimate of $0.18, according to Yahoo Finance.The shares climbed 4.50% to $10.85 as of 9:00 am ET, in premarket trading.WisdomTree’s assets under management at the end of the third quarter was $112.6 million, up from $109.7 million at the end of the second quarter. Operating revenue came in at $109.5 million compared to the $90.4 million reported for a year earlier. This was slightly shy of the consensus estimate of $110.07 million.<figure class="image"><a href="https://stocktwits.com/symbol/WT"><img style="aspect-ratio:637/135;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/wt_sentiment_34b5aa54e0.png" alt="wt-sentiment.png" width="637" height="135"></a><figcaption>WT sentiment and message volume October 25, 2024 premarket as of 9:00 am ET | Source:&nbsp;Stocktwits</figcaption></figure>Retail sentiment was ‘extremely bullish’ (95/100) with message volume reducing from a day ago, yet at ‘high.’Lyell Immunopharma, Inc. ($LYEL)Small-cap Lyell Immunopharma, a clinical-stage CART T-cell therapy biotech, said late Thursday that it has entered into a definitive agreement to acquire privately-held&nbsp; ImmPACT Bio USA Inc for $30 million in cash and 37.5 million in stock.Through the acquisition, Lyell Immunopharma will acquire worldwide rights to ImmPACT’s pipeline. The company will prioritize the development of IMPT-314 for treating B-cell lymphoma, a type of blood cancer.ImmPACT shareholders are also eligible to receive contingent consideration of 12.5 million of Lyell Immunopharma stock as milestone-based payment as well as royalties on net sales.The deal has been vetted by the board of both companies and is expected to close in the fourth quarter.The stock gained 0.94% to $1.10 in premarket trading.DexCom, Inc. ($DXCM)Glucose monitoring device manufacturer Dexcom’s shares fell in premarket trading but retail sentiment remains ‘extremely bullish.'<figure class="image"><a href="https://stocktwits.com/symbol/DXCM"><img style="aspect-ratio:632/145;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/dxcm_sentiment_f6ce5575e8.png" alt="dxcm-sentiment.png" width="632" height="145"></a><figcaption>&nbsp;DXCM sentiment and message volume October 25, 2024 premarket as of 9:00 am ET | Source:&nbsp;Stocktwits</figcaption></figure>DexCom’s third-quarter non-GAAP EPS came in at $0.45 compared to the consensus estimate of $0.43. Revenue rose 2% year-over-year from $975 million to $994.2 million. Analysts, on average, estimated a modest $990.44 million for the quarter.&nbsp;The double beat is a welcome relief after the company missed top-line expectations in the second quarter.Dexcom announced a management transition as Teri Lawver, who serves as chief commercial officer, is set to retire by the year-end. Sayer will assume her responsibilities as the company begins a search for a replacement.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dexcom-stock-plunges-despite-q3-beat-but-retail-sentiment-improves/cJ2lHI0R7u">Dexcom Stock Plunges Despite Q3 Beat But Retail Sentiment Improves</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

Dexcom and WisdomTree has cheered retailers with their earnings reports, and Lyell with an M&A transaction.

WisdomTree, Lyell Immunobiopharma, DexCom Among Stocks Retailers Are Most Bullish In Friday's Premarket

Earnings news and an M&A deal have improved retail sentiment toward these 3 stocks in Friday's premarket.

Equity

Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial

Lyell Immunopharma shares fell following the release of initial clinical data from its Phase 1 trial of LYL797, a reprogrammed CAR T-cell product. The company reported some severe cases reported in...

Lyell Immunopharma (NASDAQ:LYEL) Stock Price Up 4.9%

Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) rose 4.9% during mid-day trading on Thursday . The company traded as high as $2.17 and last traded at $2.16. Approximately 21,770...

Lyell Immunopharma (NASDAQ:LYEL) Trading 5.9% Higher

Lyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report)'s stock price traded up 5.9% during mid-day trading on Thursday . The stock traded as high as $2.17 and last traded at $2.16. 158,847 shares...

CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)

PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON 19 March 2024 -- CHARM Therapeutics ( CHARM , The Company ), a 3D deep-learning research company...

Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting

SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical stage T-cell reprogramming company advancing a diverse pipeline of cell therapies...

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023

On track to report initial clinical and translational data from lead CAR T-cell and TIL product candidates in 2024Received Orphan Drug Designation for LYL845 for the treatment of melanomaExpect to...

Commit To Buy Lyell Immunopharma At $2.50, Earn 57.3% Annualized Using Options

Investors eyeing a purchase of Lyell Immunopharma Inc (LYEL) shares, but tentative about paying the going market price of 2.84/share, might benefit from considering selling puts among the...

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.

LYEL
Lyell Immunopharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LYEL News

LYELLyell Immunopharma Inc